The impact of induction on survival after lung transplantation: An analysis of the International Society for Heart and Lung Transplantation Registry

Clinical Transplantation

Volumn 22, Issue 5, 2008, Pages 603-608

  Hachem, Ramsey R ^a   Edwards, Leah B ^b   Yusen, Roger D ^a   Chakinala, Murali M ^a   Patterson, G Alexander ^a   Trulock, Elbert P ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNITED NETWORK FOR ORGAN SHARING   (United States)

Author keywords

Induction immunosuppression; ISHLT Registry; Lung transplantation

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; CYTOKINE RECEPTOR ANTAGONIST; INTERLEUKIN 2 RECEPTOR BLOCKING AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; BRONCHIOLITIS OBLITERANS; CADAVER DONOR; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; GRAFT INFECTION; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; KAPLAN MEIER METHOD; LOG RANK TEST; LUNG FIBROSIS; LUNG GRAFT REJECTION; LUNG INSUFFICIENCY; LUNG SARCOIDOSIS; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MULTIVARIATE ANALYSIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PULMONARY HYPERTENSION; TREATMENT OUTCOME;

ANTILYMPHOCYTE SERUM; BRONCHIOLITIS OBLITERANS; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RECEPTORS, INTERLEUKIN-2; REGISTRIES; RETROSPECTIVE STUDIES; RISK; SURVIVAL ANALYSIS;

EID: 50249127907     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2008.00831.x     Document Type: Article

References (16)

1. Trulock EP, Edwards LB, Taylor DO et al. Registry of the International Society for Heart and Lung Transplantation: Twenty-second official adult lung and heart-lung transplant report - 2005. J Heart Lung Transplant 2005: 24: 956.
2. Husain AN, Siddiqui MT, Holmes EW et al. Analysis of risk factors for the development of bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 1999: 159: 829.
3. Khalifah AP, Hachem RR, Chakinala MM et al. Respiratory viral infections are a distinct risk factor for bronchiolitis obliterans syndrome and death. Am J Respir Crit Care Med 2004: 170: 181.
4. Hachem RR, Khalifah AP, Chakinala MM et al. The significance of a single episode of minimal acute rejection after lung transplantation. Transplantation 2005: 80: 1406.
5. Garrity ER, Villanueva J, Bhorade SM, Husain AN, Vigneswaran WT. Low rate of allograft rejection after the use of daclizumab, and interleukin 2 receptor antibody. Transplantation 2001: 71: 773.
6. Palmer SM, Miralles AP, Lawrence CM, Gaynor JW, Davis RD, Tapson VF. Rabbit antithymocyte globulin decreases acute rejection after lung transplantation. Chest 1999: 116: 127.
7. Charpentier B, Rostaing L, Berthoux F et al. A three-arm study comparing immediate tacrolimus therapy with anti-thymocyte globulin induction therapy followed by tacrolimus or cyclosporine A in adult renal transplant recipients. Transplantation 2003: 75: 844.
8. Opelz G, Dohler B. Lymphomas after solid organ transplantation: A collaborative transplant study report. Am J Transplant 2003: 4: 222.
9. Demissie S, La Valley MP, Horton NJ, Glynn RJ, Cupples LA. Bias due to missing exposure data using complete-case analysis in the proportional hazards regression model. Stat Med 2003: 22: 545.
10. Levine SM. A survey of clinical practice of lung transplantation in North America. Chest 2004: 125: 1224.
11. Trulock EP. Lung transplantation. Am J Respir Crit Care Med 1997: 155: 789.
12. Shennib H, Massard G, Reynaud M, Noirclerc M. Efficacy of OKT3 therapy for acute rejection in isolated lung transplantation. J Heart Lung Transplant 1994: 13: 514.
13. Valentine VG, Robbins RC, Wehner JH, Patel HR, Berry GJ, T heodore J. Total lymphoid irradiation for refractory acute rejection in heart-lung and lung allografts. Chest 1996: 109: 1184.
14. Swanson SJ, Mentzer SJ, Reilly JJ et al. Surveillance transbronchial lung biopsies: Implication for survival after lung transplantation. J Thorac Cardiovasc Surg 2000: 119: 27.
15. Tamm M, Aboyoun CL, Chhajed PN, Rainer S, Malouf MA, Glanville AR. Treated cytomegalovirus pneumonia is not associated with bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 2004: 170: 1120.
16. Kremers WK, Devarbhavi HC, Wiesner RH, Krom RAF, Macon WR, Habermann TM. Post-transplant lymphoproliferative disorders following liver transplantation: Incidence, risk factors and survival. Am J Transplant 2006: 6: 1017.